Genasys (NASDAQ:GNSS) Given New $4.50 Price Target at Roth Mkm

Genasys (NASDAQ:GNSSFree Report) had its price target upped by Roth Mkm from $3.50 to $4.50 in a research note published on Thursday, Benzinga reports. They currently have a buy rating on the stock.

Several other equities analysts have also commented on GNSS. Ascendiant Capital Markets upped their price target on Genasys from $4.25 to $4.75 and gave the company a buy rating in a research note on Monday, August 19th. Northland Securities upped their price target on Genasys from $4.50 to $6.00 and gave the company an outperform rating in a research note on Thursday, September 12th.

Get Our Latest Research Report on GNSS

Genasys Stock Performance

NASDAQ GNSS opened at $3.48 on Thursday. The stock’s fifty day moving average is $2.85 and its two-hundred day moving average is $2.35. The firm has a market capitalization of $155.20 million, a P/E ratio of -5.61 and a beta of 0.52. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.98 and a current ratio of 2.58. Genasys has a fifty-two week low of $1.51 and a fifty-two week high of $3.58.

Genasys (NASDAQ:GNSSGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.01). The company had revenue of $7.17 million for the quarter, compared to analyst estimates of $7.48 million. Genasys had a negative return on equity of 66.93% and a negative net margin of 108.72%. During the same period last year, the firm posted ($0.04) EPS. On average, research analysts anticipate that Genasys will post -0.57 earnings per share for the current year.

Insider Activity

In other news, Director Mark Culhane bought 17,587 shares of the firm’s stock in a transaction that occurred on Thursday, August 15th. The shares were purchased at an average price of $2.65 per share, with a total value of $46,605.55. Following the purchase, the director now owns 37,587 shares in the company, valued at $99,605.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.50% of the company’s stock.

Institutional Trading of Genasys

Institutional investors and hedge funds have recently bought and sold shares of the business. Victory Capital Management Inc. boosted its stake in shares of Genasys by 49.4% in the fourth quarter. Victory Capital Management Inc. now owns 30,885 shares of the company’s stock valued at $63,000 after purchasing an additional 10,212 shares during the period. BOKF NA boosted its position in Genasys by 54.8% in the 1st quarter. BOKF NA now owns 84,700 shares of the company’s stock valued at $197,000 after buying an additional 30,000 shares during the period. Cutter & CO Brokerage Inc. boosted its position in Genasys by 129.1% in the 1st quarter. Cutter & CO Brokerage Inc. now owns 120,500 shares of the company’s stock valued at $286,000 after buying an additional 67,900 shares during the period. Commonwealth Equity Services LLC acquired a new position in shares of Genasys in the second quarter worth $875,000. Finally, Pacific Ridge Capital Partners LLC increased its position in shares of Genasys by 4.2% during the fourth quarter. Pacific Ridge Capital Partners LLC now owns 1,054,481 shares of the company’s stock worth $2,141,000 after acquiring an additional 42,703 shares during the period. 40.04% of the stock is currently owned by hedge funds and other institutional investors.

Genasys Company Profile

(Get Free Report)

Genasys Inc engages in the design, development, and commercialization of critical communications hardware and software solutions to alert, inform, and protect people principally in North and South America, Europe, the Middle East, Asia, and internationally. The company operates through two segments, Hardware and Software.

See Also

Receive News & Ratings for Genasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genasys and related companies with MarketBeat.com's FREE daily email newsletter.